Amniogenesis in Human Amniotic Sac Embryoids after Exposures to Organophosphate Flame Retardants

Chenke Xu1, Chenhao Zhang1, Yanan Liu1

  • 1MOE Laboratory for Earth Surface Process, College of Urban and Environmental Sciences, Peking University, Beijing, China.

Abstract

Insights

Organophosphate flame retardants (OPFRs) can disrupt human amniogenesis, a critical step in early pregnancy. This study identifies specific OPFRs that inhibit amniogenesis in vitro, suggesting a link to early pregnancy loss.

Area of Science:

  • Reproductive toxicology
  • Developmental biology
  • Environmental health

Background:

  • Amniogenesis is vital for pregnancy; its failure can cause embryonic death.
  • The impact of environmental chemicals on amniogenesis is largely unknown.
  • Organophosphate flame retardants (OPFRs) are common environmental chemicals.

Purpose of the Study:

  • To screen environmental chemicals for their potential to disrupt amniogenesis.
  • To investigate the mechanisms by which OPFRs may cause amniogenesis failure.
  • To utilize an amniotic sac embryoid model for toxicity screening.

Main Methods:

  • Developed a high-throughput screening assay using octamer-binding transcription factor 4 (Oct4) transcriptional activity.
  • Assessed the effects of identified OPFRs on amniogenesis using time-lapse imaging.
  • Explored molecular pathways via RNA-sequencing and western blotting; identified binding targets.

Main Results:

  • Identified eight chemicals inhibiting Oct4 expression, with EHDPP and IDDPP showing the strongest effects.
  • EHDPP and IDDPP disrupted amniotic sac structure and development, affecting key embryonic markers.
  • Exposed embryoids showed abnormal phosphorylated nonmuscle myosin II (p-MLC-II) accumulation and integrin binding.

Conclusions:

  • OPFRs, specifically EHDPP and IDDPP, disrupt amniogenesis in vitro.
  • The mechanism involves inhibition of the pathway, potentially via integrin binding.
  • Provides direct evidence linking OPFR exposure to biochemical miscarriage.